Natural history of eosinophil‑derived neurotoxin levels and the onset of allergic airway disease in preschool children.

allergic airway disease atopic march eosinophil-derived neurotoxin preschool children

Journal

Experimental and therapeutic medicine
ISSN: 1792-1015
Titre abrégé: Exp Ther Med
Pays: Greece
ID NLM: 101531947

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 27 04 2023
accepted: 15 06 2023
medline: 13 11 2023
pubmed: 13 11 2023
entrez: 13 11 2023
Statut: epublish

Résumé

'Atopic march' is the progression of allergic conditions through infancy and childhood. The present study investigated the association between blood eosinophil-derived neurotoxin (EDN) levels in preschool children with food allergy (FA) or atopic dermatitis (AD) and the onset of allergic airway disease [bronchial asthma (BA), allergic rhinitis (AR)]. A total of 123 children below the age of 1 year were enrolled in the present study, along with controls (n=37). Blood specimens were taken, serum EDN levels were measured and immunoglobulin E was quantified. Finally, a total of 86 subjects were analyzed. EDN values were measured at 3 time-points: before 1 year of age, before 2 years of age and before 3 years of age. The EDN levels were initially similar between those patients who did and those who did not develop allergic airway disease but then markedly diverged at the 2-year time-point (226.6 vs. 65.0 ng/ml; P<0.01) and remained divergent at the 3-year time-point (173.9 vs. 62.7 ng/ml; P<0.01). EDN levels prior to diagnosis were compared between the two groups and they were much higher in the Onset group (n=10) compared to the Non-onset group (n=67) (171.2±34.28 vs. 81.3±10.02 ng/ml; P=0.003), with 4 cases of BA and 6 cases of AR in the Onset group. After diagnosis, EDN levels were compared twice: i) At 1 and 2 years of age; and ii) 1 and 3 years of age. A significant difference was found only in the comparison at 2 years (P=0.001). In conclusion, young children with elevated EDN levels during the FA/AD disease period were more likely to develop allergic airway disease (BA, AR) in their first three years of life. A factor leading to this progression may be increased eosinophil activity.

Identifiants

pubmed: 37954115
doi: 10.3892/etm.2023.12264
pii: ETM-26-6-12264
pmc: PMC10632952
doi:

Types de publication

Journal Article

Langues

eng

Pagination

565

Informations de copyright

Copyright © 2023, Spandidos Publications.

Déclaration de conflit d'intérêts

The authors declare that they have no competing interests.

Références

PLoS One. 2018 Dec 19;13(12):e0208472
pubmed: 30566481
Allergy Asthma Immunol Res. 2018 Nov;10(6):686-697
pubmed: 30306750
Pediatr Allergy Immunol. 2010 Jun;21(4 Pt 2):e697-704
pubmed: 20444156
Clin Exp Allergy. 1991 Sep;21(5):561-7
pubmed: 1742647
J Asthma. 2020 Nov;57(11):1211-1215
pubmed: 31298976
Int Arch Allergy Immunol. 2000 May;122(1):49-57
pubmed: 10859469
Allergy Asthma Immunol Res. 2017 Nov;9(6):466-476
pubmed: 28913985
JAMA Pediatr. 2015 Nov;169(11):e153219
pubmed: 26523822
PLoS One. 2012;7(8):e43214
pubmed: 22952649
Allergol Int. 2007 Dec;56(4):433-8
pubmed: 17965582
Pediatr Dermatol. 2016 Jul;33(4):388-98
pubmed: 27273433
J Asthma. 2010 Jun;47(5):568-73
pubmed: 20560830
J Dermatol Sci. 2001 May;26(1):79-82
pubmed: 11323224
Ann Allergy Asthma Immunol. 2018 Feb;120(2):131-137
pubmed: 29413336
J Allergy Clin Immunol Pract. 2023 Mar;11(3):750-761
pubmed: 36581068
Lung. 2007 Mar-Apr;185(2):97-103
pubmed: 17393238
JAMA. 2002 Aug 28;288(8):963-72
pubmed: 12190366
J Allergy Clin Immunol. 2018 Feb;141(2):601-607.e8
pubmed: 29153857
Allergy. 2004 Jan;59(1):26-32
pubmed: 14674929
Nat Rev Dis Primers. 2018 Jan 04;4:17098
pubmed: 29300005
J Allergy Clin Immunol. 2022 Jul;150(1):82-92
pubmed: 35150722
Allergol Int. 2017 Jan;66(1):70-74
pubmed: 27329145
Am J Respir Crit Care Med. 2000 Jan;161(1):64-72
pubmed: 10619799
BMC Pediatr. 2016 Aug 20;16:133
pubmed: 27542726
Clin Exp Allergy. 2002 Mar;32(3):361-6
pubmed: 11940064
Allergy. 2019 Oct;74(10):1835-1851
pubmed: 30953574
J Asthma. 2011 Dec;48(10):994-1000
pubmed: 22022864
Korean J Pediatr. 2015 Sep;58(9):330-5
pubmed: 26512258
Biomarkers. 2013 May;18(3):230-5
pubmed: 23557131
Clin Exp Allergy. 2008 May;38(5):709-50
pubmed: 18384431

Auteurs

Yoshihide Terashi (Y)

Department of Pediatrics, Dokkyo Medical University, Mibu, Tochigi 3210293, Japan.

Chang-Keun Kim (CK)

Department of Pediatrics, Inje University Sanggye Paik Hospital, Seoul 01757, Republic of Korea.

Zak Callaway (Z)

Department of Pediatrics, Inje University Sanggye Paik Hospital, Seoul 01757, Republic of Korea.

Jin-Sung Park (JS)

Department of Pediatrics, Kangwon National University School of Medicine, Chuncheon, Gangwon 24341, Republic of Korea.

Shinya Yoshihara (S)

Department of Pediatrics, Dokkyo Medical University, Mibu, Tochigi 3210293, Japan.

Masaya Kato (M)

Department of Pediatrics, Dokkyo Medical University, Mibu, Tochigi 3210293, Japan.

Shigemi Yoshihara (S)

Department of Pediatrics, Dokkyo Medical University, Mibu, Tochigi 3210293, Japan.

Classifications MeSH